Speakers: Professor Ahmet Fuat
This workshop has been organised and supported by Medtronic
It is estimated that around 900,000 people in the UK suffer from heart failure, and prevalence will rise due to an ageing population, improved survival rates following heart attack, and more effective treatments. HF diagnosis and management are complex with variable care provision. Some variability may relate to access to services, regardless of public or private provision. The key to reducing mortality, morbidity and costs associated with HF is early, accurate diagnosis and appropriate management.
We used a third party company to audit the Carmel Practice to assess current management, compliance with NICE guidelines and suitability for a complex CIED implant. Audit review focused on symptoms that may be compatible with HF, those with a history of myocardial infarction, percutaneous or surgical coronary intervention or atrial fibrillation, the last echocardiogram/ECG, ejection fraction 35% or moderate severe LVSD and use of prognostic HF drugs. The case finder element of GRASP-HF was used to identify patients with HF / LVSD that had not been correctly coded in GP records. Any patients identified as suitable for clinical review were invited to attend a face to face consultation for an up to date ECG and also to implement an appropriate management plan. If needed, patients were referred by the GPSI / Cardiologist into secondary/tertiary care for CIED management and/or treatment optimisation. Outcomes after each patient clinical review were / are being assessed up to 12-months.